A phase II study of weekly low-dose paclitaxel plus 24-hour infusion of cisplatin as first-line chemotherapy for metastatic breast cancer (MBC)

被引：0
|
作者：
Shen, Y. [1 ]
Hsu, C. [1 ]
Kuo, S. [1 ]
Lu, Y. [1 ]
Lin, C. [1 ]
Huang, C. [1 ]
Cheng, A. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1100
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer
    Blum, Joanne L.
    Dees, E. Claire
    Chacko, Aparna
    Doane, Lisa
    Ethirajan, Sukumar
    Hopkins, Judith
    McMahon, Richard
    Merten, Suzan
    Negron, Angel
    Neubauer, Marcus
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390
  • [22] Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
    Hartung, G
    Hofheinz, RD
    Wein, A
    Riedel, C
    Rost, A
    Fritze, D
    Kreuser, ED
    Drees, M
    Kühnel, J
    Hehlmann, R
    Queisser, W
    ONKOLOGIE, 2001, 24 (05): : 457 - 462
  • [23] Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial
    ten Tije, AJ
    Smorenburg, CH
    Seynaeve, C
    Sparrebooma, A
    Schothorst, KLC
    Kerkhofs, LGM
    van Reisen, LGPM
    Stoter, G
    Bontenbal, M
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 352 - 357
  • [24] Preliminary results of a Phase II study of low dose weekly paclitaxel (TXL) plus high dose tremifene (TOR) in patients with metastatic breast cancer (MBC)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 169 - 169
  • [25] 1-hour infusion weekly Paclitaxel as first-line treatment in advanced breast cancer
    Ranuzzi, M
    Scirocchi, R
    Teodori, T
    Garritan, G
    Russo, F
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 197 - 197
  • [26] Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study
    Klaassen, U
    Wilke, H
    Harstrick, A
    Pari, CP
    Strumberg, D
    Newmann, K
    Eberhardt, W
    Achterrath, W
    Lenaz, L
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 (01) : 45 - 50
  • [27] Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
    Yeh, KH
    Lu, YS
    Hsu, CH
    Lin, JF
    Hsu, C
    Kuo, SH
    Li, SJ
    Cheng, AL
    ONCOLOGY, 2005, 69 (01) : 88 - 95
  • [28] Weekly 1-hour paclitaxel as first line chemotherapy for advanced and metastatic breast cancer
    Wist, EA
    Sommer, HH
    Oestenstad, B
    Risberg, T
    Fjaestad, K
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 138 - 138
  • [29] Weekly paclitaxel, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin (weekly TP-HDFL) in patients with metastatic or recurrent esophageal cancer
    Huang, T.
    Tsai, Y.
    Lin, C.
    Cheng, A.
    Yeh, K.
    Hsu, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] A clinical phase II study of cisplatin and vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer (MBC).
    Yassine, H
    Khalifeh, M
    Bitar, N
    Charafeddine, M
    Dheiny, M
    Chehal, A
    Jalloul, R
    Dandashi, A
    Wehbeh, M
    Shamseddine, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 83S - 83S
12345